Navigation Links
Ferring Pharmaceuticals' EUFLEXXA(TM) to Serve as Sponsor for Sprint Force America Masters Track Club
Date:4/18/2008

l fluid and the most highly purified HA product available today. In addition, since it is not derived from an avian source (chicken or rooster combs), the risk of reactions related to avian proteins is eliminated.(3-8)

EUFLEXXA(TM) received PMA approval from the U.S. Food and Drug Administration (FDA) on December 3, 2004, and became available to the public on November 8, 2005. For more information, visit http://www.EUFLEXXA.com.

(1) IMS National Sales Perspective Data, February 2008

(2) Kirchner M, Marshall D. A double-blind randomized controlled trial comparing alternate forms of high molecular weight hyaluronan for the treatment of osteoarthritis of the knee. Osteoarthritis Cartilage. 2006; 14:154-162.

(3) Schiavinato A, Finesso M, Cortivo R, & Abatangelo G. Comparison of the effects of intra-articular injections of Hyaluronan and its chemically cross-linked derivative (Hylan G-F20) in normal rabbit knee joints. Clin Exp Rheumatol. 2002; 20: 445-454.

(4) Goomer RS, Leslie K, Maris T, & Amiel D. Native hyaluronan produces less hypersensitivity than cross-linked hyaluronan. Clin Orthop Relat Res. 2005; 434: 239-245.

(5) Leopold SS, Warme WJ, Pettis PD, & Shott S. Increased frequency of acute local reaction to intra-articular hylan GF-20 (synvisc) in patients receiving more than one course of treatment. J Bone Joint Surg Am. 2002; 84-A: 1619-1623.

(6) Puttick MP, Wade JP, Chalmers A, Connell DG, & Rangno KK. Acute local reactions after intraarticular hylan for osteoarthritis of the knee. J Rheumatol. 1995; 22: 1311-1314.

(7) Pullman-Mooar S, Mooar P, Sieck M, Clayburne G, & Schumacher HR. Are there distinctive inflammatory flares after hylan g-f 20 intraarticular injections? J Rheumatol. 2002; 29: 2611-2614.

(8) Chen AL, Desai P, Adler EM, & Di Cesare PE. Granulomatous inflammation after Hylan G-F 20 viscosupplementation of the knee: a report of six case
'/>"/>

SOURCE Ferring Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Ferring Announces $10,000 Grand Prize Winner of 2007 My Little Miracle Essay Contest
2. Access Pharmaceuticals Announces New Data on Angiolix(R)
3. Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results
4. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results
5. Sunesis Pharmaceuticals Presents Nonclinical Data on SNS-595 at the Annual Meeting of the American Association for Cancer Research
6. Alexion Pharmaceuticals Invites You to Participate in its First Quarter 2008 Results Conference Call and Web Cast
7. Access Pharmaceuticals to Present New Data on ProLindac(TM) at the AACR Annual Meeting 2008 Conference
8. ISTA Pharmaceuticals Announces Receipt of Subpoena Relating to Promotional Practices for XIBROM(TM)
9. Aida Pharmaceuticals, Inc. Announces New Antibiotic Drug Under Development
10. Bayer HealthCare Pharmaceuticals, Amerinet Extend Contrast Media Agreement
11. Idenix Pharmaceuticals to Present at the Canaccord Adams Hepatitis C Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)..., HATBORO,Pa.,Nov.23/PRNewswire-FirstCall/--InfoL...rofenterprisemobilitysolutionsforthehealthcareandc...rVicePresidentofManagedServicesatSiemensHealthServ...ealthcareServices. ,, (Logo: http://www.newscom...icePresidentofStrategicHealthcareServicesforInfoLo...
(Date:11/23/2009)...TLAND, Ore. Low-income children who don,t access ...he long term are significantly more likely to have...ccording to a new study published in the journal ... informing the financing and delivery of quality h..., "In the current policy debates about health in...
(Date:11/23/2009)...erships doubled number of patients who reined in t...DAY, Nov. 23 (HealthDay News) -- High blood pressu... working hand-in-hand than by doctors and pharmaci...hysicians work with pharmacists, medications are i...re effectively," said Barry L. Carter, a professor...
(Date:11/23/2009)..., PartnershipswithMinorityBanksin Washington ...f. and Columbia , S.C. IntendedtoSpurEconomic...RNewswire-USNewswire/--DaVita,thenation,sleadingpr...MinorityBankInitiativedesignedtocreatejobsandspurr...withinvestmentsinleadingcommunityandminority-owned...
(Date:11/23/2009)..., TUCSON,Ariz.,Nov.23/PRNewswire/--CortivaInstitu...shoponSunday,Dec.6from1-3p.m.attheschool,s6390East...yforparticipantstolearnandpracticebasicmassagestro...aInstituteTucsonisgrowingrightalongwithit,"saidJoa..., Infact,theU.S.DepartmentofLabor,s2009-2010Occupa...
Breaking Medicine News(10 mins):Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 2Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 3Health News:Children who lack continuity with a regular health care provider miss needed services 2Health News:Children who lack continuity with a regular health care provider miss needed services 3Health News:Doctor-Pharmacist Teams Boost Blood Pressure Control 2Health News:Doctor-Pharmacist Teams Boost Blood Pressure Control 3Health News:DaVita Launches Minority Bank Initiative with $5 Million Investment in Underserved Communities Across the Country 2Health News:DaVita Launches Minority Bank Initiative with $5 Million Investment in Underserved Communities Across the Country 3Health News:Cortiva Institute To Host Workshop, Hands-On Opportunity for Prospective Students 2
... 14 LifeVantage,Corporation (OTC Bulletin Board: ...wn as President and Chief Executive Officer of the...orporation is the maker of,Protandim(R), a clinica...the Board of LifeVantage said, "David,Brown is a s...
... Natural,Harmony Foods, Inc. (Pink Sheets: NHYF),...rotein-rich foods announced today that the company...work to combat childhood,obesity. Natural Harmony ...ade with delicious, juicy beef and pork, but are,a...
...nternational,Isotopes Inc. (OTC Bulletin Board: IN...s Mayer as Chief Operating Officer (COO)., James ...ting Officer on,January 11, 2008. Mr. Mayer receiv... at Lincoln. He has over 25,years of management ex...
... coherence tomography,(OCT) is a unique imaging mo...ptics technology to date in the field of disease d... first commercialized for medical,imaging applicat...the potential to supplant existing imaging technol...
...aceutical,Laboratories, Ltd., (Amex: CPD ) announ... (FDA) has granted final approval for the Company,...rizine Hydrochloride,Chewable Tablets, "over-the-c...ths, 5 mg and 10 mg, is an antihistamine drug, whi...
...ing from spinach to meat to children,s snacks , ...ittle less than a year and a half, the list of tai...nd the impact on people is stark: , , An E. coli b...and Canada. , Salmonella in batches of Peter Pan a...
Other Medicine News:Health News:LifeVantage Corporation Appoints Industry Veteran David Brown as President & CEO 2Health News:LifeVantage Corporation Appoints Industry Veteran David Brown as President & CEO 3Health News:LifeVantage Corporation Appoints Industry Veteran David Brown as President & CEO 4Health News:Natural Harmony Foods Works to Reduce Childhood Obesity 2Health News:Natural Harmony Foods Works to Reduce Childhood Obesity 3Health News:International Isotopes Inc. Names James Mayer as Chief Operating Officer 2Health News:Optical Coherence Tomography Market to Top $800 Million by 2012 2Health News:Optical Coherence Tomography Market to Top $800 Million by 2012 3Health News:Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Children's Zyrtec(R) Chewable Tablets for Allergy Relief and Children's Zyrtec(R) Chewable Tablets for Hives Relief 2Health News:U.S. Food Safety: A Grocery List of Tainted Products 2
(Date:11/23/2009)...ov.23/PRNewswire/--TwooftheChicagoarea,sleadingBoa...werainwomen,sbreastimaging,couplingthelatesttechno...ltrasoundwiththeabilitytohavethefullrangeofdigital...ntbeforesheleavestheoffice.Drs.AhmedFaragandJoanWe...outthecurrent6-9monthwaitforanappointmentcommonlyf...
(Date:11/23/2009)...ss.,Nov.23/PRNewswire-FirstCall/--BostonScientific...hePiperJaffrayHealthCareConference,December1-2. ,...dSamLeno,ExecutiveVicePresidentandChiefFinancialOf...eCompanyonTuesday,December1st,beginningatapproxima...nwillbeavailabletoallinterestedpartiesatBostonScie...
(Date:11/23/2009)...MOND,Calif.,Nov.23/PRNewswire-FirstCall/--Transcep...thatitisscheduledtomeetwiththeU.S.FoodandDrugAdmin...ResponseLetterregardingtheNewDrugApplication(NDA)f...ablet).Aspreviouslyannounced,theCompleteResponseLe...thattheFDAcouldnotapprovetheNDAinitspresentform.Th...
Breaking Medicine Technology:Transcept Pharmaceuticals Scheduled to Meet With FDA to Discuss Intermezzo(R) Complete Response Letter 2Prize4Life Marks One Year Anniversary of Avi Kremer ALS Treatment Prize 59217 1Prize4Life Marks One Year Anniversary of Avi Kremer ALS Treatment Prize 59217 2Prize4Life Marks One Year Anniversary of Avi Kremer ALS Treatment Prize 59217 3Pieris Reports Preclinical Development Progress of its Next Generation VEGF Antagonist 14410 1Pieris Reports Preclinical Development Progress of its Next Generation VEGF Antagonist 14410 2Pieris Reports Preclinical Development Progress of its Next Generation VEGF Antagonist 14410 3Stereotaxis Announces Pricing of 2426 Million Common Stock Offering 5364 1Stereotaxis Announces Pricing of 2426 Million Common Stock Offering 5364 2Stereotaxis Announces Pricing of 2426 Million Common Stock Offering 5364 3
... Today at the American Academy of Pain,Medicine,s... of California at,San Diego report that no standa...al steroid injection for back pain. Researchers l...re given, the amount of steroid used, and whether,...id. , Epidural steroid injections (ESI) are mi...
... Jan. 28 Savient Pharmaceuticals, Inc. (Nasdaq: ... application (BLA) for pegloticase for treatment-f...sory Committee appointed by the U.S. Food and Drug... for a drug of a new therapeutic class. , , S... 2008 seeking approval to market pegloticase in th...
Other Medicine Technology:Study Shows No Standardized Approach to Epidural Steroid Injections for Back Pain 2Savient Announces FDA's Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients 2Savient Announces FDA's Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients 3Savient Announces FDA's Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients 4
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
Medicine Products: